Factor XII deficiency is strongly associated with primary recurrent abortions

被引:48
作者
Pauer, HU [1 ]
Burfeind, P [1 ]
Köstering, H [1 ]
Emons, G [1 ]
Hinney, B [1 ]
机构
[1] Univ Hosp Gottingen, Gottingen, Germany
关键词
D O I
10.1016/S0015-0282(03)00788-X
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Objective: To evaluate factor XII deficiency in women with primary and secondary recurrent abortion. Design: Prospective case-control study. Setting: University hospital. Patient(s): Sixty-seven women with primary and 33 women with secondary recurrent abortion of unexplained nature and 49 healthy controls with no history of thrombotic disease or adverse pregnancy outcomes. Main Outcome Measure(s): Plasma factor XII activity, activated protein C resistance, factor V Leiden mutation analysis, protein C, protein S, antithrombin III, karyotyping, and anticardiolipin antibodies. Result(s): Ten of 67 women with primary recurrent abortion (14.9%) and 4 of 33 women (12.1%) with secondary recurrent abortion had reduced factor XII activity (<60%). These results are highly significant in the former group and showed a tendency toward significance in the latter group. All controls had normal factor XII activity. Conclusion(s): Factor XII deficiency is strongly associated with primary recurrent abortion, and women with secondary recurrent abortion show a tendency toward factor XII deficiency. (C) 2003 by American Society for Reproductive Medicine.
引用
收藏
页码:590 / 594
页数:5
相关论文
共 34 条
  • [1] Fibrinolytic properties of activated FXII
    Braat, EAM
    Dooijewaard, G
    Rijken, DC
    [J]. EUROPEAN JOURNAL OF BIOCHEMISTRY, 1999, 263 (03): : 904 - 911
  • [2] BRAULKE I, 1993, FERTIL STERIL, V59, P98
  • [3] Structure/function analysis of human factor XII using recombinant deletion mutants - Evidence for an additional region involved in the binding to negatively charged surfaces
    Citarella, F
    Ravon, DM
    Pascucci, B
    Felici, A
    Fantoni, A
    Hack, CE
    [J]. EUROPEAN JOURNAL OF BIOCHEMISTRY, 1996, 238 (01): : 240 - 249
  • [4] Activated factor XII levels and factor XII 46C &gt;T genotype in relation to coronary artery calcification in patients with type 1 diabetes and healthy subjects
    Colhoun, HM
    Zito, F
    Chan, NN
    Rubens, MB
    Fuller, JH
    Humphries, SE
    [J]. ATHEROSCLEROSIS, 2002, 163 (02) : 363 - 369
  • [5] Measurement of activated factor XII in health and disease
    Coppola, R
    Cristilli, P
    Cugno, M
    Ariens, RAS
    Mari, D
    Mannucci, PM
    [J]. BLOOD COAGULATION & FIBRINOLYSIS, 1996, 7 (05) : 530 - 535
  • [6] Spontaneous thrombosis in mice carrying the factor V Leiden mutation
    Cui, JS
    Eitzman, DT
    Westrick, RJ
    Christie, PD
    Xu, ZJJ
    Yang, AY
    Purkayastha, AA
    Yang, TL
    Metz, AL
    Gallagher, KP
    Tyson, JA
    Rosenberg, RD
    Ginsburg, D
    [J]. BLOOD, 2000, 96 (13) : 4222 - 4226
  • [7] Fetal carriers of the factor V Leiden mutation are prone to miscarriage and placental infarction
    DizonTomson, DS
    Meline, L
    Nelson, LM
    Warner, M
    Ward, K
    [J]. AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1997, 177 (02) : 402 - 405
  • [8] Lethal perinatal thrombosis in mice resulting from the interaction of tissue factor pathway inhibitor deficiency and Factor V Leiden
    Eitzman, DT
    Westrick, RJ
    Bi, XM
    Manning, SL
    Wilkinson, JE
    Broze, GJ
    Ginsburg, D
    [J]. CIRCULATION, 2002, 105 (18) : 2139 - 2142
  • [9] FARSETTI A, 1995, ENDOCRINOLOGY, V136, P5076, DOI 10.1210/en.136.11.5076
  • [10] Genetic risk factors of venous thrombosis
    Franco, RF
    Reitsma, PH
    [J]. HUMAN GENETICS, 2001, 109 (04) : 369 - 384